all report title image

ORAL VACCINES MARKET ANALYSIS

Oral Vaccines Market, by Vaccine Type (Live Attenuated, Inactive, Recombinant, and Others), by Application (Polio, Tuberculosis, Rabies, Influenza, Cholera, and Others), by End User (Hospitals, Clinics, Government Organizations, and Others), and by Region (North America, Europe, Latin America, Asia Pacific, Africa, and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI3467
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Leading Companies

Global Oral Vaccines Market – Competitive Landscape

Key player in oral vaccines market are focused on strategic mergers and acquisitions to promote their product in global market. For instance, in February 2019, Bharat Biotech acquired Chiron Behring vaccines, a manufacturer of rabies vaccine and subsidiary of GlaxoSmithKline. The acquisition enhanced Bharat Biotech offerings for rabies vaccine and strengthened its market presence.  

Key players operating in the global oral vaccines market include GlaxoSmithKline, Sanofi, Merck, Serum Institute of India pvt ltd, Swiss serum and vaccine institute Brene, Janssen pharmaceuticals, Paxvax corporation ltd, Valneva Canada, Shanghai Bravo bio Co ltd, Abbott Biologicals, MSD, Novavax, and Takeda.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.